Myelodysplastic syndromes (MDS) are clonal malignant hematopoietic problems within the aged characterised by ineffective hematopoiesis. That is accompanied by an altered bone microenvironment, which contributes to MDS development and better
Myelodysplastic syndromes (MDS) are clonal malignant hematopoietic problems within the aged characterised by ineffective hematopoiesis. That is accompanied by an altered bone microenvironment, which contributes to MDS development and better